Certis Oncology Solutions

Healthcare Software · California, United States · 50 Employees

Certis Oncology Solutions was formed in 2016 with the mission to provide individualized treatment options to cancer patients. Our technology enables oncologists to determine with precision the most effective available therapies to treat each patient's unique disease. Pharmaceutical companies leverage our expertise in precision oncology to obtain accurate, scientifically relevant data for preclinical decision-making. Findings from our science can dramatically improve lead optimization of new drug candidates, reduce development risk, and expedite the path to clinical trials.Read More

View Company Info for Free

Who is Certis Oncology Solutions

Headquarters

5626 Oberlin Dr Ste 110, San Diego, California, 92121, United States

Phone Number

(858) 228-4110

Website

www.certisoncology.com

Revenue

$10.5M

Industry

Healthcare Software

Software Development & Design

Software

Is this data correct?

View contact profiles from Certis Oncology Solutions

Popular SearchesCertis Oncology Solutions IncCertis Oncology SolutionsCertis OncologyCertis Oncology PartnersCertisOncologySIC Code 73,737NAICS Code 51,518Show More

Certis Oncology Solutions Org Chart

Peter Ellman

Chief Executive Officer

Phone

Scott Arnold

Executive Vice President & C...

Phone

View Email Formats for Certis Oncology Solutions

Certis Oncology Solutions Tech Stack

Java

Oracle

Microsoft Excel

Microsoft

Sched

Salesforce

See more technologies

Top Companies in United States

Certis Oncology Solutions News & Media

Certis Oncology Named 'Overall Immunology Company of the Year' in 2023 BioTech Breakthrough Awards
SAN DIEGO--(BUSINESS WIRE)-- #CertaintySavesLives--Certis Oncology Solutions has been selected as "Overall Immunology Company of the Year" in the third annual BioTech Breakthrough Awards program.
Nov 9, 2023
www.businesswire.com
Certis Oncology Solutions Highlights AI & Machine Learning With Advanced Preclinical Cancer Models for Improved Clinical Translation in Upcoming Webinar Hosted by Xtalks
In this live webinar, learn how an AI-enabled preclinical oncology strategy can identify biomarkers that are predictive of therapeutic response, elucidate the synergistic potential of combinatory therapies and optimize preclinical development using in vitro and in vivo models developed...
Sep 28, 2023
www.prweb.com
SOTERIA Precision Medicine Foundation Opens Cancer Research Study Leveraging Certis Oncology Solutions’ Predictive Artificial Intelligence Platform and Functional Assays
SAN DIEGO--(BUSINESS WIRE)-- #CertaintySavesLives--SOTERIA Precision Medicine Foundation, an organization dedicated to empowering patients, caregivers, and clinicians with the power of precision medicine, today announced a fiscal sponsorship agreement with Certis Oncology Solutions, a San Diego-based precision oncology and translational science company. The agreement will support an observational clinical research study aimed at validating the application of “mouse avatars” as a clinically relev
Jun 8, 2023
www.businesswire.com
AI in Cancer Research: Optimizing Biomarker Discovery, Model Selection, and Preclinical Decision-Making, Upcoming Webinar, Hosted by Xtalks
In this upcoming live webinar, learn about how to use Artificial Intelligence (AI) to predict the efficacy of an investigational compound and identify the most relevant models to test. Attendees will gain insights about using AI to prioritize the most promising compounds and rank cancer types most likely to respond to a lead candidate. Certis Oncology Solutions’ Director of Bioinformatics and Data Science, Long H. Do, PhD, will discuss employing machine learning (ML) technologies to
Apr 25, 2023
www.prweb.com
Certis Oncology Solutions Launches Predictive Analytics Platform
SAN DIEGO--(BUSINESS WIRE)-- #ArtificialIntelligence--Certis Oncology Solutions (“Certis”), a precision oncology and translational science company focused on combining functional assays and artificial intelligence to advance personalized medicine, today announced the launch of CertisAI™, a new predictive medicine platform that utilizes big data, statistical algorithms, and machine learning to predict drug efficacy based on gene expression biomarkers. This pan-cancer solution can accelerate drug
Apr 13, 2023
www.businesswire.com